Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat.
Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into people. Many scientists believe that is how the COVID-19 pandemic began, with SARS-CoV-2, the virus responsible for COVID-19, originating from a family of coronaviruses found in bats.
Now, researchers from the UCSF Quantitative Biosciences Institute, Icahn School of Medicine at Mount Sinai, Institut Pasteur, and Fred Hutchinson Cancer Center have uncovered evidence that a single amino acid change in a coronavirus protein can dramatically alter how the virus interacts with the immune systems of bats and humans. Their findings offer new insight into how an otherwise harmless animal virus can evolve into one capable of causing serious disease in people.
The research was published in Cell Host & Microbe.
A Tiny Genetic Difference With a Big Impact
To investigate what allows some coronaviruses to infect humans, the team compared SARS-CoV-2 with a closely related bat coronavirus called RaTG13, which infects bats but is not known to infect people. Using the first laboratory-grown lung cell line developed from the greater horseshoe bat, the researchers examined how each virus interacted with immune proteins in both bat and human lung cells.
One viral protein, known as OrfB9, stood out. The SARS-CoV-2 and RaTG13 versions of OrfB9 differ by just one amino acid out of roughly 100, yet that tiny difference had striking effects.
In human lung cells, the SARS-CoV-2 version of OrfB9 shut down an important immune alarm system, allowing the virus to replicate more easily. In bat lung cells, the RaTG13 version had the opposite effect, activating an immune protein that helped keep the virus under control.
Clues to How Viruses Cross Species
The discovery highlights how even the smallest genetic changes can influence whether a virus remains confined to animals or gains the ability to infect humans.
"The difference between a virus that stays in bats and one that spills over into humans and causes catastrophic disease can come down to remarkably small genetic changes," said Nevan J. Krogan, PhD, director of QBI and senior author of the study. "By mapping these interactions at the protein level — across two viruses and two species — we can read the molecular signatures that predict spillover risk. It's the kind of early warning system the world needs."
By identifying the molecular changes that alter interactions between viruses and the immune system, the researchers hope their work will improve scientists' ability to recognize animal viruses with the greatest potential to spill over into humans before they spark future outbreaks.
Reference: "Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential" by Jyoti Batra, Magdalena Rutkowska, Yuan Zhou, Chengjin Ye, Rithika Adavikolanu, Janet M. Young, Durga Anand, Sooraj Verma, Haripriya Parthasarathy, Martin Gordon, Shivali Malpotra, Anastasija Cupic, Thomas Kehrer, Melanie Dos Santos, Ronald Benjamin, Jack M. Moen, Declan M. Winters, Vincent Caval, Ajda Rojc, Ignacio Mena, Sadaf Aslam, Carles Martinez-Romero, Isabela Conde Viñas, Zain Khalil, Keith Farrugia, Fernando Villalón-Letelier, Atoshi Banerjee, Dafna Tussia-Cohen, Amy Diallo, Sourobh Maji, Monita Muralidharan, Helene Foussard, Irene P. Chen, Rotem Fuchs, C.J. San Felipe, Lorena Zuliani-Alvarez, Promisree Choudhury, Kirsten Obernier, Ségolène Gracias, Rahul K. Suryawanshi, Boris Bonaventure, Carlos Ibáñez, Jeffrey R. Johnson, Javier Juste, Lars Pache, Robert M. Stroud, Kliment A. Verba, James S. Fraser, Harm van Bakel, Taha Y. Taha, Melanie Ott, Tzachi Hagai, Nolwenn Jouvenet, Caroline Demeret, Benjamin J. Polacco, Danielle L. Swaney, Ignacia Echeverria, Mehdi Bouhaddou, Manon Eckhardt, Harmit S. Malik, Luis Martinez-Sobrido, Lisa Miorin, Adolfo García-Sastre and Nevan J. Krogan, 13 May 2026, Cell Host & Microbe.
DOI: 10.1016/j.chom.2026.04.015
Authors: UCSF authors are Jyoti Batra, PhD; Yuan Zhou, MS; Rithika Adavikolanu; Durga Anand; Sooraj Verma; Martin Gordon, MS; Shivali Malpotra, MS; Jack M. Moen, PhD; Ajda Rojc, MS; Atoshi Banerjee, PhD; Sourobh Maji, PhD; Monita Muralidharan, PhD; Helene Foussard, PhD; Irene P. Chen, PhD; CJ San Felipe, PhD; Lorena Zuliani-Alvarez, PhD; Promisree Choudhury, PhD; Kirsten Obernier, PhD; Rahul Suryawanshi, PhD; Taha Y. Taha, PhD, PharmD; Kliment A. Verba, PhD; James S. Fraser, PhD; Robert M. Stroud, PhD, MA; Melanie Ott, MD, PhD; Ben Polacco, PhD; Danielle L. Swaney, PhD; Ignacia Echeverria, PhD; and Manon Eckhardt, PhD. For all authors see the paper.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine. Moderna has initiated a Phase I trial of its mRNA Ebola vaccine [...]
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]















